Wellington Management Group’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Buy |
137,066
+1,106
| +0.8% | +$12.6K | ﹤0.01% | 1625 |
|
|
2025
Q1 | $904K | Buy |
135,960
+1,148
| +0.9% | +$7.63K | ﹤0.01% | 1720 |
|
|
2024
Q4 | $1.49M | Sell |
134,812
-2,163
| -2% | -$23.9K | ﹤0.01% | 1632 |
|
|
2024
Q3 | $1.68M | Sell |
136,975
-6,661
| -5% | -$81.9K | ﹤0.01% | 1575 |
|
|
2024
Q2 | $1.94M | Buy |
143,636
+285
| +0.2% | +$3.85K | ﹤0.01% | 1514 |
|
|
2024
Q1 | $1.94M | Buy |
+143,351
| New | +$1.94M | ﹤0.01% | 1528 |
|
|
2023
Q4 | – | Sell |
-174,332
| Closed | -$687K | – | 1920 |
|
|
2023
Q3 | $687K | Buy |
174,332
+5,044
| +3% | +$19.9K | ﹤0.01% | 1656 |
|
|
2023
Q2 | $1.8M | Sell |
169,288
-31,609
| -16% | -$336K | ﹤0.01% | 1498 |
|
|
2023
Q1 | $1.67M | Sell |
200,897
-411,157
| -67% | -$3.42M | ﹤0.01% | 1544 |
|
|
2022
Q4 | $5.65M | Sell |
612,054
-651,345
| -52% | -$6.01M | ﹤0.01% | 1239 |
|
|
2022
Q3 | $16.2M | Buy |
1,263,399
+5,286
| +0.4% | +$67.9K | ﹤0.01% | 976 |
|
|
2022
Q2 | $16.6M | Buy |
1,258,113
+69,998
| +6% | +$925K | ﹤0.01% | 987 |
|
|
2022
Q1 | $25M | Buy |
+1,188,115
| New | +$25M | ﹤0.01% | 964 |
|
|
2020
Q4 | – | Sell |
-54,750
| Closed | -$1.83M | – | 2008 |
|
|
2020
Q3 | $1.83M | Buy |
54,750
+39,302
| +254% | +$1.32M | ﹤0.01% | 1428 |
|
|
2020
Q2 | $368K | Sell |
15,448
-115,732
| -88% | -$2.76M | ﹤0.01% | 1712 |
|
|
2020
Q1 | $3M | Sell |
131,180
-56,068
| -30% | -$1.28M | ﹤0.01% | 1296 |
|
|
2019
Q4 | $5.3M | Buy |
187,248
+42,325
| +29% | +$1.2M | ﹤0.01% | 1321 |
|
|
2019
Q3 | $3.12M | Sell |
144,923
-261,548
| -64% | -$5.62M | ﹤0.01% | 1460 |
|
|
2019
Q2 | $11.9M | Buy |
+406,471
| New | +$11.9M | ﹤0.01% | 1157 |
|